X

Trial Profile

Imatinib in combination with cytarabine as compared to imatinib alone in patients with first chronic phase chronic myeloid leukemia. A prospective randomised phase III study.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 15 Jan 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cytarabine (Primary) ; Imatinib (Primary)
Indications Chronic myeloid leukaemia
Focus Therapeutic Use
Acronyms HOVON-78-CML

Most Recent Events

16 Aug 2014 New source identified and integrated (European Clinical Trials Database record:EudraCT2005-003839-41)
01 Oct 2013 According to the European Clinical Trials database record, trial status is completed.
01 Aug 2013 Results published in the Annals of Hematology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com